The Canadian Generic Pharmaceutical Association (CGPA) has launched an ad campaign directed at senior executives. With rising costs to employee benefits plans, mandatory generic substitution – a clause built into plans that ensures pharmacists substitute generic medicines in place of expensive brand name drugs – is more important than ever.
The pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association have successfully negotiated a Renewed Three-Year Generics Initiative
The pan-Canadian Pharmaceutical Alliance (pCPA), consisting of participating federal, provincial, and territorial government public drug plans and the Canadian Generic Pharmaceutical Association (CGPA) have successfully reached an agreement on a renewed three-year pricing initiative for generic medicines that will help public drug plans continue to control their costs.
The Canadian Generic Pharmaceutical Association (CGPA) today launched an advertising campaign, created by leading advertising and design firm, Key Gordon Communications Inc, to highlight the cost savings Canadians see from using generic medicines — and the savings that could be realized if more generic medications were used.
Nanos poll finds 87 percent of Ontarians believe government should prioritize policies to strengthen domestic generic pharmaceutical industry.
Ray Shelley of Apotex Elected Chair of Canadian Generic Pharmaceutical Association ; Michel Robidoux of Sandoz Elected Vice Chair
The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Ray Shelley, Senior Vice President, Commercial Operations – Canada and Rest of World Markets at Apotex Inc., as Chair of CGPA.